Leadership

Oncology experts drive the GIRO initiative to advocate for equitable access to radiotherapy as an essential part of multidisciplinary cancer care

Mei Ling Yap

Current Position
Mei Ling Yap is a staff specialist radiation oncologist and director of training at Liverpool and Macarthur Cancer Therapy Centres, Sydney, Australia. She holds a conjoint senior lecturer appointment with the University of Western Sydney and University of New South Wales and an adjunct senior lecturer appointment with the University of Sydney.

Training
From 2007-2012, Mei Ling undertook her radiation oncology speciality training in Australia, Singapore and Canada. Mei Ling is currently undertaking a PhD with the University of NSW, Cancer Council NSW and Collaboration for Cancer Outcomes Research and Evaluation (CCORE), exploring the socio-demographic factors which influence radiotherapy utilization in Australia.

Main Interests and Global Collaborations
Mei Ling was a member of the Global Task Force in Radiotherapy on Cancer Control (GTFRCC) and co-author of the Lancet Oncology Commission. Mei Ling is co-chair of the Asia Pacific Radiation Oncology Special Interest Group (APROSIG-RANZCR), which supports LMIC radiotherapy departments in the Asia-Pacific through a bilateral exchange, training and education. She also co-runs GlobalRT, an online platform advocating for equitable access to radiotherapy globally. Mei Ling was selected as a UICC ‘Young Cancer Leader’ in 2015.

Short Statement
The marked inequity in access to radiotherapy in low and middle-income countries is a current global health crisis. Every cancer patient should have access to this cost-effective, beneficial treatment. I am excited to be able to collaborate with international colleagues who are dedicated to working on this issue, through the GIRO project.